Literature DB >> 6253556

Differences in secretion characteristics in Cushing's disease with and without radiologically evident pituitary tumors.

S W Lamberts1, J G Klijn, F H de Jong, J C Birkenhäger.   

Abstract

In a group of 22 unselected patients with Cushing's disease 3 had a moderately enlarged pituitary fossa, while 6 patients showed asymmetry of the sella turcica at lateral tomography. This group of 9 patients with radiologically evident pituitary adenomas had:i) a higher average basal urinary excretion of 17-hydroxycorticosteroids which showed a greater day to day variation;ii) a greater (although insufficient) decrease of plasma cortisol in response to a single oral dose of 1 mg dexamethasone and larger postdexamethasone rebound excretion of urinary 17-hydroxycorticosteroids after 8 mg dexamethasone daily for two days; and iii) a larger maximal increase of plasma cortisol after lysine vasopressin administration than the other 13 patients. The increase in the size of a pituitary (micro-) adenoma in patients with Cushing's disease is accompanied by a more severe hypercortisolism and an increased responsiveness of the pituitary-adrenal axis to the manipulations mentioned.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253556     DOI: 10.1007/BF03348272

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  DIAGNOSIS OF CUSHING'S SYNDROME; SINGLE DOSE DEXAMETHASONE SUPPRESSION TEST.

Authors:  C A NUGENT; T NICHOLS; F H TYLER
Journal:  Arch Intern Med       Date:  1965-08

2.  ACTH-producing pituitary tumors following adrenalectomy for Cushing's syndrome.

Authors:  D H NELSON; J W MEAKIN; G W THORN
Journal:  Ann Intern Med       Date:  1960-03       Impact factor: 25.391

3.  Studies of ACTH secretion control in 116 cases of Cushing's syndrome.

Authors:  M C Raux; M Binoux; J P Luton; M Gourmelen; F Girard
Journal:  J Clin Endocrinol Metab       Date:  1975-02       Impact factor: 5.958

4.  Body composition in Cushing's disease.

Authors:  S W Lamberts; J C Birkenhäger
Journal:  J Clin Endocrinol Metab       Date:  1976-05       Impact factor: 5.958

5.  Cure of Cushing's disease by transsphenoidal removal of a microadenoma from a pituitary gland despite a radiographically normal sella turcica.

Authors:  S T Bigos; F Robert; G Pelletier; J Hardy
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

6.  Hydrocortisone-production rates in Africans.

Authors:  J H Thijssen; F De Waard; A Wiersinga
Journal:  Lancet       Date:  1967-04-15       Impact factor: 79.321

7.  Determination of dehydroepiandrosterone and dehydroepiandrosterone sulphate in human plasma using electron capture detection of 4-androstene-3,6,17-trione after gas-liquid chromatography.

Authors:  F H de Jong; H J van der Molen
Journal:  J Endocrinol       Date:  1972-06       Impact factor: 4.286

8.  A simple method for the separate determination of cortisol and corticosterone in plasma.

Authors:  W Eechaute
Journal:  Clin Chim Acta       Date:  1966-06       Impact factor: 3.786

9.  Evaluation of diagnostic and differential diagnostic tests in Cushing's syndrome.

Authors:  S W Lamberts; F H De Jong; J C Birkenhäger
Journal:  Neth J Med       Date:  1977       Impact factor: 1.422

10.  Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.

Authors:  D T Krieger; M Luria
Journal:  J Clin Endocrinol Metab       Date:  1977-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.